AFRM
Same bull, smaller number
Citizens just trimmed its price target on Affirm (AFRM) to $85 from $105, but left the stock with a Market Outperform stamp. In other words: not a breakup text, more like “you’re still great, just maybe don’t text me 20 times a day.”
Why this matters
Affirm has been on a heater lately — the shares are up 24% over the past week — so a target cut like this is mostly the market’s way of asking, “Okay, but how much of the good news is already in the price?” When a stock runs hard, even believers start doing the valuation math with a slightly squinted eye.
The Street is still split, but not broken
Citizens isn’t alone in the Affirm soap opera. Morgan Stanley recently reiterated an Overweight rating with a $76 target, pointing to possible estimate revisions and a cleaner catalyst path. Baird, meanwhile, stayed Neutral with a $55 target, flagging macro gremlins like high fuel prices and private credit headaches.
That’s the vibe here: nobody’s calling the story over, but the easy-money phase may be behind it. If you own AFRM, you’re not just betting on growth — you’re betting that growth can keep outrunning the valuation police.
Big picture: Affirm’s still getting plenty of Street love, but this is what happens when a stock rallies fast: the praise stays, the price targets get a little less enthusiastic, and everyone suddenly becomes a part-time risk manager.